Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. Hydrobromide, Hydroxyamphetamine
2. Hydroxyamfetamine
3. Hydroxyamphetamin
4. Hydroxyamphetamine
5. Hydroxyphenylisopropylamine
6. Methyltyramine
7. Norpholedrin
8. Oxyamphetamine
9. P Hydroxyamphetamine
10. P-hydroxyamphetamine
11. Para Hydroxyamphetamine
12. Para-hydroxyamphetamine
13. Paredrine
1. 306-21-8
2. Predrolon
3. Paredrine Hydrobromide
4. 4-(2-aminopropyl)phenol Hydrobromide
5. P-hydroxyamphetamine Hydrobromide
6. Hydroxyamfetamine Hydrobromide
7. Hydroxyamfetamine Hbr
8. Hydroxyamphetamine Hbr
9. Phenol, 4-(2-aminopropyl)-, Hydrobromide
10. 4-(2-aminopropyl)phenol;hydrobromide
11. Nsc-61065
12. 2-amino-1-(4-hydroxyphenyl)propane Hydrobromide
13. 3-(p-hydroxyphenyl)-2-aminopropane Hydrobromide
14. 59ig47sz0e
15. Phenol,4-(2-aminopropyl)-, Hydrobromide (1:1)
16. Phenol, 4-(2-aminopropyl)-, Hbr
17. Hydroxyamphetamine Hydrobromide [usp]
18. 140-36-3
19. Ncgc00095233-01
20. Mycadrine
21. Hydroxyamphetamine Hydrobromide (usp)
22. Hydroxyamfetamin Hydrobromid
23. (+-)-paredrine Hydrobromide
24. Einecs 206-181-4
25. Nsc 61065
26. Dl-p-(2-aminopropyl)phenol Hydrobromide
27. Unii-59ig47sz0e
28. (+-)-p-(2-aminopropyl)phenol Hydrobromide
29. 1-p-hydroxyphenyl-2-aminopropane Hydrobromide
30. Paredrine (tn)
31. Beta-(p-hydroxyphenyl)isopropylamine Hydrobromide
32. Phenol, P-(2-aminopropyl)-, Hydrobromide, (+-)-
33. Phenol, Hydrobromide
34. Component Of Paredrine
35. Phenol, P-(2-aminopropyl)-, Hydrobromide
36. Cid_9377
37. Hyroxyamfetamine Hydrobromide
38. Dsstox_cid_25961
39. Dsstox_rid_81257
40. Dsstox_gsid_45961
41. Spectrum211425
42. Mls002320672
43. Mls002320674
44. Schembl221647
45. Chembl1200705
46. Dtxsid0045961
47. Oxamphetamine Hydrobromide
48. Wln: Zy1&1r Dq &eh
49. Hms1923c15
50. Pharmakon1600-00211425
51. Nsc61065
52. Tox21_111487
53. Nsc760066
54. P-(2-aminopropyl)phenol Hydrobromide
55. P-(2-aminopropyl)phenyl Hydrobromide
56. (+)-4-hydroxyamphetamine Hydrobromide
57. Ccg-213716
58. Nsc-760066
59. (+/-)-4-hydroxyamphetamine Hydrobromide
60. Ncgc00095233-02
61. Cas-306-21-8
62. Smr001338818
63. Smr001338820
64. Hydroxyamphetamine Hydrobromide [mi]
65. (+/-)-p-(2-aminopropyl)phenol Hbr
66. Hydroxyamfetamine Hydrobromide [mart.]
67. Hydroxyamphetamine Hydrobromide [vandf]
68. D04473
69. Hydroxyamfetamine Hydrobromide [who-dd]
70. Hydroxyamphetamine Hydrobromide [usp-rs]
71. (+/-)-p-(2-aminopropyl)phenol Hydrobromide
72. .beta.-(p-hydroxyphenyl)isopropylamine Hydrobromide
73. Hydroxyamphetamine Hydrobromide [orange Book]
74. Hydroxyamphetamine Hydrobromide [usp Monograph]
75. Q27261708
76. Rac. 4-hydroxy-alpha-methylphenethylamine Hydrobromide
77. Paremyd Component Hydroxyamphetamine Hydrobromide
78. Hydroxyamphetamine Hydrobromide Component Of Paremyd
| Molecular Weight | 232.12 g/mol |
|---|---|
| Molecular Formula | C9H14BrNO |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 2 |
| Exact Mass | 231.02588 g/mol |
| Monoisotopic Mass | 231.02588 g/mol |
| Topological Polar Surface Area | 46.2 Ų |
| Heavy Atom Count | 12 |
| Formal Charge | 0 |
| Complexity | 108 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Sympathomimetics
Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. (See all compounds classified as Sympathomimetics.)
Mydriatics
Agents that dilate the pupil. They may be either sympathomimetics or parasympatholytics. (See all compounds classified as Mydriatics.)
Related Excipient Companies
Excipients by Applications
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
24
PharmaCompass offers a list of P-Hydroxyamphetamine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right P-Hydroxyamphetamine manufacturer or P-Hydroxyamphetamine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred P-Hydroxyamphetamine manufacturer or P-Hydroxyamphetamine supplier.
PharmaCompass also assists you with knowing the P-Hydroxyamphetamine API Price utilized in the formulation of products. P-Hydroxyamphetamine API Price is not always fixed or binding as the P-Hydroxyamphetamine Price is obtained through a variety of data sources. The P-Hydroxyamphetamine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Phenol, 4-(2-aminopropyl)-, hydrobromide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Phenol, 4-(2-aminopropyl)-, hydrobromide, including repackagers and relabelers. The FDA regulates Phenol, 4-(2-aminopropyl)-, hydrobromide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Phenol, 4-(2-aminopropyl)-, hydrobromide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Phenol, 4-(2-aminopropyl)-, hydrobromide supplier is an individual or a company that provides Phenol, 4-(2-aminopropyl)-, hydrobromide active pharmaceutical ingredient (API) or Phenol, 4-(2-aminopropyl)-, hydrobromide finished formulations upon request. The Phenol, 4-(2-aminopropyl)-, hydrobromide suppliers may include Phenol, 4-(2-aminopropyl)-, hydrobromide API manufacturers, exporters, distributors and traders.
click here to find a list of Phenol, 4-(2-aminopropyl)-, hydrobromide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Phenol, 4-(2-aminopropyl)-, hydrobromide DMF (Drug Master File) is a document detailing the whole manufacturing process of Phenol, 4-(2-aminopropyl)-, hydrobromide active pharmaceutical ingredient (API) in detail. Different forms of Phenol, 4-(2-aminopropyl)-, hydrobromide DMFs exist exist since differing nations have different regulations, such as Phenol, 4-(2-aminopropyl)-, hydrobromide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Phenol, 4-(2-aminopropyl)-, hydrobromide DMF submitted to regulatory agencies in the US is known as a USDMF. Phenol, 4-(2-aminopropyl)-, hydrobromide USDMF includes data on Phenol, 4-(2-aminopropyl)-, hydrobromide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Phenol, 4-(2-aminopropyl)-, hydrobromide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Phenol, 4-(2-aminopropyl)-, hydrobromide suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Phenol, 4-(2-aminopropyl)-, hydrobromide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Phenol, 4-(2-aminopropyl)-, hydrobromide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Phenol, 4-(2-aminopropyl)-, hydrobromide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Phenol, 4-(2-aminopropyl)-, hydrobromide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Phenol, 4-(2-aminopropyl)-, hydrobromide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Phenol, 4-(2-aminopropyl)-, hydrobromide suppliers with NDC on PharmaCompass.
Phenol, 4-(2-aminopropyl)-, hydrobromide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Phenol, 4-(2-aminopropyl)-, hydrobromide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Phenol, 4-(2-aminopropyl)-, hydrobromide GMP manufacturer or Phenol, 4-(2-aminopropyl)-, hydrobromide GMP API supplier for your needs.
A Phenol, 4-(2-aminopropyl)-, hydrobromide CoA (Certificate of Analysis) is a formal document that attests to Phenol, 4-(2-aminopropyl)-, hydrobromide's compliance with Phenol, 4-(2-aminopropyl)-, hydrobromide specifications and serves as a tool for batch-level quality control.
Phenol, 4-(2-aminopropyl)-, hydrobromide CoA mostly includes findings from lab analyses of a specific batch. For each Phenol, 4-(2-aminopropyl)-, hydrobromide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Phenol, 4-(2-aminopropyl)-, hydrobromide may be tested according to a variety of international standards, such as European Pharmacopoeia (Phenol, 4-(2-aminopropyl)-, hydrobromide EP), Phenol, 4-(2-aminopropyl)-, hydrobromide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Phenol, 4-(2-aminopropyl)-, hydrobromide USP).